Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Gecko

Product Description

Gecko 150 pixels JPEG1.jpgThe Gecko Microplate & Petri  Barcode Labeller is designed to deal with the day to day needs of either a high throughput or medium to low throughput lab. With a small footprint allowing limited bench space to be used, the Gecko is a versatile and robust instrument. With a Z-axis movement meaning that no adaptors are required and all label sizes able to be used the Gecko is a versatile, robust and reliable instrument. The Gecko uses either a 300dpi or 600dpi Zebra or Cab printer which is supplied as standard with the system and prints up to six fields (bar codes and human readable) per label. The label can be applied to one or all sides of the microplate and can withstand temperatures of -800C to 1000C. KBiosystems Gecko applies the label then verifies it using a mounted barcode reader before releasing the plate to give the end user full confidence. The data sources are numerous and can be comma-or tab delimited files and spread sheets, 3rd party application driven, pre-printed (sample feed and supply) and with an ODBC compliant LIMS.

The Gecko is easily integrated with stacking robots/stackers from KBiosystems as well as other systems and also be integrated within any OEM plate supply provider. The Gecko is the ideal printing and labelling solution in the market today with the added reassurance of dealing directly with the manufacturer.

Product Gecko
Company KBiosystems
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

KBiosystems
Units 5 to 10 Paycocke Close Basildon Essex

Tel: +44 (0) 1268 522431
Fax: +44 (0) 1268 270231
Email: sales@kbiosystems.com



Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!